机译:177Lu-PSMA-617前列腺特异膜抗原(PSMA)抑制剂对去势抵抗性前列腺癌患者的正常器官和组织的治疗前剂量
Department of Nuclear Medicine Cerrahpasa Medical Faculty Istanbul University">(1);
Department of Nuclear Medicine Cerrahpasa Medical Faculty Istanbul University">(1);
Department of Nuclear Medicine Cerrahpasa Medical Faculty Istanbul University">(1);
Department of Nuclear Medicine Cerrahpasa Medical Faculty Istanbul University">(1);
Department of Pharmaceutical Technology Pharmacy Faculty Istanbul University">(2);
Department of Nuclear Medicine Sisli Etfal Training and Research Hospital">(3);
Department of Nuclear Medicine Yeditepe University Medical Faculty">(4);
Prostate cancer; Radionuclide treatment; Prostate specific membrane antigen; PSMA; Lu-177-PSMA; Castration resistant; Radiometabolic therapy;
机译:Lu-177-PSMA-617前列腺特异性膜抗原(PSMA)抑制剂对去势抵抗性前列腺癌患者的正常器官和组织的治疗前剂量
机译:Lu-177-PSMA-617对去势抵抗性前列腺癌患者的前列腺特异性膜抗原抑制剂治疗:稳定性,生物分布和剂量学
机译:正电子发射断层扫描与(68)镓(GA) - 标记的前列腺特异性膜抗原(PSMA)在自由基治疗和自由基前列腺切除术后管理患有器官狭窄和局部晚期前列腺癌患者的作用
机译:前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
机译:影像学前列腺癌:光学和放射性前列腺特异性膜抗原(PSMA)抑制剂的设计,合成和生物学评估
机译:Lu-177-PSMA-617对去势抵抗性前列腺癌患者的前列腺特异性膜抗原抑制剂治疗:稳定性生物分布和剂量学
机译:Lu-177-psma-617前列腺特异性膜抗原抑制剂治疗去势抵抗性前列腺癌患者:稳定性,生物分布和剂量学